Balyasny Asset Management LLC Amicus Therapeutics, Inc. Transaction History

Balyasny Asset Management LLC

$58 Billion
Q3 2024

A detailed history of Balyasny Asset Management LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 150,000 shares of FOLD stock, worth $1.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

150,000

Previous 1,117,100 86.57%

Holding current value

$1.5 Million

Previous $11.1 Million 85.54%

% of portfolio

0.0%

Previous 0.02%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$9.55 - $12.09 $7.62 Million - $9.65 Million	797,883 Added 71.42%	1,914,983 $20.5 Million
Q2 2024 Aug 14, 2024	BUY	$9.04 - $11.75 $10.1 Million - $13.1 Million	1,117,100 New	1,117,100 $11.1 Million
Q4 2023 Feb 14, 2024	SELL	$9.97 - $14.52 $18.2 Million - $26.6 Million	-1,828,892 Reduced 54.02%	1,556,540 $22.1 Million
Q3 2023 Nov 14, 2023	BUY	$11.78 - $13.86 $1.89 Million - $2.22 Million	160,399 Added 4.97%	3,385,432 $41.2 Million
Q2 2023 Aug 14, 2023	BUY	$10.72 - $13.3 $11.9 Million - $14.7 Million	1,106,425 Added 52.22%	3,225,033 $40.5 Million
Q1 2023 May 15, 2023	BUY	$10.91 - $13.54 $1.3 Million - $1.61 Million	118,752 Added 5.94%	2,118,608 $23.5 Million
Q4 2022 Feb 14, 2023	BUY	$9.89 - $12.7 $3.11 Million - $4 Million	314,888 Added 18.69%	1,999,856 $24.4 Million
Q3 2022 Nov 14, 2022	SELL	$9.82 - $12.75 $4.6 Million - $5.97 Million	-468,116 Reduced 21.74%	1,684,968 $17.6 Million
Q2 2022 Aug 15, 2022	BUY	$6.23 - $11.12 $13.4 Million - $23.9 Million	2,153,084 New	2,153,084 $23.1 Million
Q2 2021 Aug 16, 2021	SELL	$8.71 - $10.72 $117,306 - $144,376	-13,468 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$9.2 - $23.86 $123,905 - $321,346	13,468 New	13,468 $133,000
Q4 2020 Feb 16, 2021	SELL	$13.47 - $24.89 $309,594 - $572,071	-22,984 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$12.89 - $15.89 $296,263 - $365,215	22,984 New	22,984 $325,000
Q4 2017 Feb 14, 2018	SELL	$12.51 - $16.24 $161,379 - $209,495	-12,900 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$11.74 - $15.78 $151,446 - $203,562	12,900	12,900 $195,000

Others Institutions Holding FOLD

# of Institutions

313

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.8B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Amicus Therapeutics, Inc. Transaction History